FY2024 Earnings Forecast for The Cooper Companies, Inc. (NASDAQ:COO) Issued By William Blair

The Cooper Companies, Inc. (NASDAQ:COO) – Analysts at William Blair raised their FY2024 earnings per share estimates for shares of Cooper Companies in a report issued on Wednesday, September 4th. William Blair analyst M. Kaczor now expects that the medical device company will post earnings of $3.65 per share for the year, up from their prior forecast of $3.57. The consensus estimate for Cooper Companies’ current full-year earnings is $3.66 per share. William Blair also issued estimates for Cooper Companies’ Q4 2024 earnings at $0.99 EPS, Q1 2025 earnings at $0.95 EPS, Q2 2025 earnings at $0.97 EPS, Q4 2025 earnings at $1.07 EPS and FY2025 earnings at $4.06 EPS.

A number of other brokerages have also recently commented on COO. Jefferies Financial Group upgraded Cooper Companies from a “hold” rating to a “buy” rating and lifted their target price for the stock from $107.00 to $115.00 in a report on Tuesday, July 16th. Wells Fargo & Company lifted their target price on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a report on Thursday, August 29th. Stifel Nicolaus reiterated a “buy” rating and issued a $115.00 target price (up previously from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Finally, Piper Sandler lifted their target price on Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Four investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $113.61.

Cooper Companies Stock Performance

NASDAQ:COO opened at $106.50 on Thursday. The company has a market cap of $21.21 billion, a price-to-earnings ratio of 62.65, a PEG ratio of 2.56 and a beta of 0.98. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99 and a quick ratio of 1.14. The stock’s 50 day simple moving average is $92.92 and its two-hundred day simple moving average is $94.55. Cooper Companies has a 1 year low of $75.93 and a 1 year high of $107.46.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The business had revenue of $1 billion for the quarter, compared to the consensus estimate of $997.30 million. During the same quarter in the previous year, the company posted $0.84 EPS. The company’s revenue was up 7.8% compared to the same quarter last year.

Hedge Funds Weigh In On Cooper Companies

A number of large investors have recently bought and sold shares of COO. Sanctuary Advisors LLC purchased a new stake in shares of Cooper Companies in the 2nd quarter worth $3,043,000. Cetera Investment Advisers lifted its holdings in shares of Cooper Companies by 6.3% in the 2nd quarter. Cetera Investment Advisers now owns 22,244 shares of the medical device company’s stock worth $1,942,000 after buying an additional 1,309 shares during the period. B. Riley Wealth Advisors Inc. lifted its holdings in shares of Cooper Companies by 113.1% in the 2nd quarter. B. Riley Wealth Advisors Inc. now owns 2,529 shares of the medical device company’s stock worth $221,000 after buying an additional 1,342 shares during the period. Quarry LP lifted its holdings in shares of Cooper Companies by 1,225.9% in the 2nd quarter. Quarry LP now owns 2,718 shares of the medical device company’s stock worth $237,000 after buying an additional 2,513 shares during the period. Finally, Wallace Advisory Group LLC purchased a new stake in shares of Cooper Companies in the 2nd quarter worth $290,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.